Isolation of a somatomedin binding protein from human preterm amniotic fluid : development of a radioimmunoassay


Doctoral Thesis
Related Files
asset icon
(831014_Drop, Stenvert Leonard Sebastiaan.pdf, 3.0MB)
asset icon
(Stellingen Drop, Stenvert Leonard Sebastiaan.pdf, 0.1MB)

This thesis study was undertaken in order to investigate the nature and biological behavior of a somatornedin binding protein, identified in preterrn amniotic fluid (AF). Somatomedin (SM) is the generic designation applied to a family of serum peptide growth factors which are growth hormone dependent, stimulate incorporation of sulphate into cartilage, have insulin-like actions on nonskeletal tissues and increase mitosis in a wide variety of cultured cells. Thusfar two peptides have been fully characterized: insulin-like growth factor I (IGF-I), shown to be identical to sornatomedin-C, and insulin-like growth factor II (IGF-II). IGF-I and IGF-II have a 62% aminoacid sequence identity and are 38-48% homologous with the A and B domains of human pro-insulin.



Keywords


Automatically Extracted Terms
  • serum
  • protein
  • binding
  • growth
  • activity
  • value
  • fluid
  • somatomedin
  • plasma
  • hormone
  • weight
  • factor
  • column
  • fraction
  • assay
  • effect
  • study
  • insulin-like
  • concentration
  • chromatography